ReleaseWire Connect

According to a research report by Transparency Market Research (TMR), the global myasthenia gravis market is anticipated to be worth US$2,313.1 mn by the end of 2025 from a valuation of US$975.1 mn in 2016. During the forecast period of 2017 and 2025, the global myasthenia gravis market is projected to clock a CAGR of 10.1%.

Metastatic breast cancer involves cases where the cancer has spread from the breasts to other organs in the human body, thereby resulting in malignancy. According to World Health organization (WHO) in 2012, around 521,000 people died due to breast cancer and this number is expected to increase in the near future. Like other metastatic cancers, surgical removal of metastatic breast cancer is deemed ineffective and often results in increased chance of death (nearly 80% - 90% of the diagnosed population). Prognosis is generally based on the stage of breast cancer in the patient; this staging is done by the usual TNM staging method, wherein T stands for tumor, N stands for node swelling, followed by M i.e. the metastatic stage of the cancer. These symptoms are used in the classification of metastatic breast cancer into 4 stages, stages 1- 3 involves gradual spread of carcinoma from various regions of the breast but doesn't involve metastasis; stage 4 shows a full blown metastasis which shows involvement of lymph nodes near or distant from the breasts and spread to other organs including bones, lung and the brain. Bone cancer is the most commonly reported (around 70% of cases) form of cancer originating from metastasis of breast cancer. Recurrence of cancer in stage 3 and stage 4 patients show lesser chance of successful prognosis. Systemic chemotherapy drugs (along with anti estrogen compounds, dpending upon the oncologists' inference) are usually prescribed to target cancer cells.

Metastatic breast cancer involves cases where the cancer has spread from the breasts to other organs in the human body, thereby resulting in malignancy. According to World Health organization (WHO) in 2012, around 521,000 people died due to breast cancer and this number is expected to increase in the near future. Like other metastatic cancers, surgical removal of metastatic breast cancer is deemed ineffective and often results in increased chance of death (nearly 80% - 90% of the diagnosed population). Prognosis is generally based on the stage of breast cancer in the patient; this staging is done by the usual TNM staging method, wherein T stands for tumor

According to the research report, the global erythropoietin drugs market is expected to be worth US$19,379.2 mn by the end of 2025 as it surges at CAGR of 7.5% from 2017 to 2025.

According to the latest report compiled by Transparency Market Research (TMR), the global single-use bioreactors market is expected to witness robust growth. It is also estimated to increase to 13.5% CAGR throughout the forecast period 2017-2026. The market is also projected to reach US$ 1,547.3 million revenue by 2026 end.

Transparency Market Research has announced the addition of the “Anti-Venom Market Anti-Venom Market Global Industry Analysis and Opportunity Assessment, 2017-2025" report to their offering.

Transparency Market Research has announced the addition of the “Antithrombin Market Global Industry Analysis and Opportunity Assessment, 2017 - 2025"report to their offering.

Fosfomycin calcium is a bactericidal agent with low toxicity levels and low cross-resistance level with other antibiotics. Known simply as fosfomycin or oral fosfomycin, it acts as an anti-infective agent by killing sensitive bacteria present in the affected body part. This substance exhibits high level of activity when used against gram positive and gram negative bacteria. White or yellow colored in the powdered form, fosfomycin can be used as an additive in drinking water and animal feed.

Population health management is characterized as collecting and analyzing the data on segments of patient population and management of that data for specific diseases within that population. It is a model which helps the health care providers and payers to assess the populations they serve across the continuum of care. Population health management is thus a comprehensive approach which requires both analysis and action, and utilized to uncover the gaps in health care for the benefits of patients and physicians. It improves health management outcomes by aligning physicians, coordinating the medical care, and optimizing efficiency as well as revenue. Major factors driving the population health management market are continued pressures to minimize health care costs, rising demand to improve the healthcare services quality, and implementation of value-based payment system. However, lack of trained and efficient professionals, safety of data and its management concerns, and lack of proper systems requiring investment to run the population health management program smoothly are the major restraints of the population health management market.

Boston Scientific, Inc., Abbott Laboratories, Terumo Europe NV, Biotronik, and Biosensors International have been the five leaders in the global intraocular lens market for 2016, when they collectively held a massive 80.5% of the market. According to a research report released by Transparency Market Research, the leading players in this highly consolidated market have so far managed to generate a significant global reach. In the coming years, most of them are likely to focus on more clinical trials and examinations for creating better intraocular lenses and prove their superiority over other competitive products and substitutes. The players are also expected to show more interest in research and development activities that will further enhance their products and product portfolios. The TMR report reveals that the global intraocular lens market stood at US$3.2 bn in 2015. The market is expected to expand at a CAGR of 5.2% within the given forecast period from 2016 to 2024, eventually reaching US$5.0 bn by the end of 2024. intraocular lens market Cataract Procedures on the Rise